About Coppax EVC Compounding
Coppax EVC Compounding is a leading UK veterinary pharmaceutical manufacturer specialising in equine medicines. They produce unlicensed (extemporaneous) formulations that fill critical gaps where no licensed alternatives exist — including products such as equine levothyroxine.
For veterinary practices across the UK, Coppax EVC is a trusted partner, ensuring horses receive essential, often life-saving, medicines when no commercial options are available.
The Challenge
Operating within a tightly regulated environment, Coppax EVC needed a blending solution that would deliver:
- – Consistent, repeatable homogeneity
- – Full alignment with Good Manufacturing Practice (GMP)
- – Faster turnaround times for urgent veterinary requirements
- – Scalable capacity to meet rising product demand
- – A credible, audit-ready process that strengthened trust with equine vets
Without the right equipment, the business faced production bottlenecks, limited flexibility, and constraints on growth — with potential impact on the availability of crucial veterinary medicines.
The Solution: MB1200 Multiblend Powder Blender
In 2017, Coppax EVC partnered with Terriva to modernise their production process through the installation of the Terriva MB1200 Multiblend Powder Blender.
The MB1200 delivered the ideal combination of compliance, performance, and scalability:
- GMP-ready construction
All-stainless build, CE-marked, and supplied with full validation support for audit confidence. - Consistent, homogenous blends
The asymmetric tilting action ensures exceptional uniformity batch after batch. - Scalable capacity
Supports batch weights up to 350 kg and multiple IBC, drum, and vessel formats — enabling long-term production growth. - Operational efficiency and safety
Automated lifting and tilting reduce manual handling, downtime, and operator risk.
The Results
Since installation, the MB1200 has become a core part of Coppax EVC’s daily manufacturing workflow — delivering measurable operational and clinical benefits:
- Faster turnaround times to support urgent veterinary needs
- Stronger credibility among equine vets due to improved GMP alignment
- Ongoing growth and repeat business driven by reliable production
- Patient impact through consistent supply of life-saving equine medications
“Terriva were able to talk us through vessel sizes, GMP requirements and different mixing machines. They have a huge amount of experience in this area.”
— Coppax EVC Compounding
Continuing Partnership
Building on the success of the MB1200, Coppax EVC are once again expanding their capabilities with Terriva — investing in new drums and vessels to:
- Eliminate cross-contamination testing costs (saving up to £20,000 per product)
- Strengthen GMP compliance across a growing product portfolio
- Support development of new sterile injection products for equine healthcare
This long-term collaboration reflects how Coppax EVC view Terriva — as a committed partner in their compliance, efficiency, and growth journey.
Why This Matters for Veterinary and Specialist Manufacturers
Coppax EVC Compounding’s experience highlights the transformative impact of choosing the right blending technology. The Terriva MB1200 enables manufacturers to:
- Maintain GMP-aligned, audit-ready production
- Scale with confidence as demand increases
- Build trust through reliable, consistent blending
- Ensure supply of essential medicines where licensed alternatives do not exist
Terriva continues to support specialist manufacturers in achieving reliable, compliant, and scalable powder-processing operations — ultimately contributing to improved patient outcomes.
If you’re looking for a more reliable, compliant and scalable blending process, we can help.
From consultation to installation and ongoing support, Terriva helps manufacturers achieve consistency, compliance and growth.